ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 820

In Rheumatoid Arthritis Incident Fractures Are Associated with an Increased Risk of Cardiovascular Events

Orla Ni Mhuircheartaigh1, Cynthia S. Crowson2, Sherine E. Gabriel3, Veronique L. Roger4, L. Joseph Melton III5 and Shreyasee Amin6, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 3Health Sciences Research & Div of Rheumatology, Mayo Clinic, Rochester, MN, 4Health Sciences Research and Cardiology, Mayo Clinic, Rochester, MN, 5Department of Hlth Sciences, Mayo Clinic, Rochester, MN, 6Health Sciences Research and Rheumatology, Mayo Clinic, Rochester, MN

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease, fractures, inflammation and rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoporosis and Metabolic Bone Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid Arthritis (RA) is associated with an increased risk for both fracture (fx) and cardiovascular disease (CVD) and there is increasing evidence establishing a link between these conditions. In addition to common shared risk factors (e.g., smoking), chronic inflammation may also be key to the pathogenesis of bone loss and CVD. Our aim was to determine whether an incident fx following RA diagnosis increases the risk for subsequent CVD.

Methods: We studied a population-based inception cohort (age ≥18 yrs) who fulfilled 1987 ACR criteria for RA between 1955 and 2007 and an equal number of age- and sex-matched non-RA subjects from the same underlying population. All incident fxs, CVD events (including ischemic heart disease [IHD] and heart failure [HF]) and CVD risk factors (smoking, diabetes mellitus, hypertension, dyslipidemia) were identified through a review of complete (inpatient and outpatient) community medical records. Pathologic fxs and fxs resulting from severe trauma (e.g., motor vehicle accidents) were excluded from analyses. Subjects with prior CVD were also excluded. Adjusting for age, sex, calendar year and CVD risk factors, Cox proportional hazard models were used to examine the risk for CVD following incident fx (modeled as a time-dependent covariate) in both RA and non-RA subjects. CVD risk factors were also modeled as time-dependent covariates.

Results:   We identified 1171 RA and 1171 non-RA subjects (for each group: mean age ± SD, 57 ± 16 yrs; 822 [70%] women), of whom 137 RA and 139 non-RA subjects with prior CVD were excluded. Over a follow-up of 14,125 person-years (py) (median, 10 years) and 16,125 py (median, 12 years) for RA and non-RA subjects, respectively, 406 RA and 346 non-RA subjects had an incident fx and 284 RA and 225 non-RA subjects developed CVD. Among RA subjects, but not non-RA subjects, there was an increased risk for CVD following an incident fx (Table). Results were similar following a fx at a major osteoporotic fx site (hip, spine, wrist, shoulder) [results not shown].

Hazard Ratio* (95% CI) for CVD following Incident Fx

Any CVD

IHD

HF

RA subjects

1.80 (1.35, 2.40)

1.56 (1.10, 2.20)

1.81 (1.32, 2.47)

Non-RA subjects

1.12 (0.77, 1.62)

1.09 (0.71, 1.68)

1.07 (0.70, 1.63)

* adjusted for age, sex, calendar year and CVD risk factors

Conclusion:  In women and men with RA, an incident fracture is associated with an increased risk of subsequent CVD. Although the mechanism underlying this association remains to be clarified, a new fx in an RA patient should be considered a sentinel event that prompts further evaluation of their cardiovascular risk.


Disclosure:

O. Ni Mhuircheartaigh,
None;

C. S. Crowson,
None;

S. E. Gabriel,

Pfizer Inc,

2,

Roche Pharmaceuticals,

5;

V. L. Roger,
None;

L. J. Melton III,
None;

S. Amin,

Merck Pharmaceuticals,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/in-rheumatoid-arthritis-incident-fractures-are-associated-with-an-increased-risk-of-cardiovascular-events/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology